Cash Conversion

Cash Conversion

The margin-of-safety case depends on something the prior chapters asserted but did not test: that Cognizant's reported profit is real cash. It largely is. Over 2021–2025 operating cash flow converted net income at about 1.1 times, capital intensity is under 2% of revenue, stock-based pay is small, and the "adjusted" earnings back out a net gain at the operating line rather than a pile of charges. Two caveats temper it: the headline free-cash-flow yield leans on 2025's strong print, and receivables are drifting.

Profit turns into cash, but not evenly

Across five years Cognizant generated $12.4 billion of operating cash flow against $11.0 billion of net income — a cumulative conversion of roughly 1.12x. But the year-to-year path is lumpy. Conversion dipped below 1.0x in 2024, when operating cash flow fell to $2.12 billion and free cash flow to $1.83 billion [1], then rebounded to $2.88 billion of operating cash flow and $2.6 billion of free cash flow in 2025 [2].

Loading...

Source: derived from FY2023–FY2025 10-Ks, Consolidated Statements of Cash Flows [3]. Free cash flow = operating cash flow less capital expenditure.

5-yr Cash Conversion (OCF/NI)

1.12

2025 Free Cash Flow ($M)

$2,595

Capex / Revenue

1.3%

Stock-Based Pay ($M)

$181

Source: derived from FY2021–FY2025 10-Ks, cash-flow and income statements [4].

Two features stand out before any adjustment. Capital expenditure is trivial — $288 million in 2025, about 1.3% of revenue — so operating cash flow drops through to free cash flow almost intact; this is an asset-light services model, not a capex compounder. And stock-based compensation is only $181 million, under 1% of revenue and roughly 8% of net income [5]. For a technology employer of 351,600 people, that is a restrained use of equity — the free cash flow is not being quietly handed to staff and bought back at a loss.

Two one-off tax items, not deteriorating quality

The swing from 0.95x conversion in 2024 to 1.29x in 2025 looks alarming until it is decomposed. Both endpoints are distorted by identifiable, non-recurring tax events, and stripping them out leaves conversion almost flat at ~1.1x in both years.

The 2024 trough was deepened by a $360 million payment made in January 2024 to settle a dispute with the Indian Income Tax Department — a cash outflow the company names explicitly as having reduced that year's operating cash flow [6]. Add it back and 2024 operating cash flow is about $2.48 billion, or 1.11x net income.

The 2025 spike is the mirror image. In the third quarter of 2025 Cognizant booked a $390 million one-time, non-cash income tax charge tied to the One Big Beautiful Bill Act, which repealed the requirement to capitalize research costs and rendered a deferred tax asset unrealizable [7]. That charge cut GAAP net income and diluted EPS by $0.80 [8] — which is why reported net income was flat at $2.23 billion even as income from operations rose 17% to $3.39 billion [9]. Because the charge is non-cash, it added straight back in the cash-flow statement (deferred taxes swung by $682 million year-over-year), so operating cash flow was untouched. Normalizing net income up by $390 million puts 2025 conversion at 1.10x — the same as the adjusted 2024 figure.

Notably, the same OBBBA change that hurt GAAP earnings helped cash: the repeal reduced 2025 cash taxes by roughly $200 million versus the company's prior projections [10]. GAAP earnings understate the 2025 cash story, not the reverse — the opposite of the pattern a skeptic usually finds.

Receivables are the slow leak worth watching

The clearest drag on quality is working capital. Trade receivables consumed $366 million of cash in 2025, up from $49 million in 2024 and $43 million in 2023 [11]. The company's own days-sales-outstanding measure — which includes contract assets, net of deferred revenue — rose from 77 days at the end of 2023 to 78 in 2024 and 81 in 2025 [12], and reached 84 days in the first quarter of 2026, up three days both sequentially and year-over-year [13].

Loading...

Source: FY2025 10-K, Liquidity and Capital Resources [14]; Q1 FY2026 earnings call [15].

Four days of DSO across two years is not a crisis — collections are still well inside a normal services-industry band, and the first quarter is seasonally the weakest for cash (Q1 2026 free cash flow was about $200 million, held down by the annual bonus payout) [16]. But the direction is consistent, and it ties directly to the re-pricing described in The Nonlinearity Test. The DSO metric includes contract assets, and as the fixed-price and outcome-based book grows toward half of revenue and deal durations lengthen, more revenue is recognized ahead of billing. The nonlinear re-pricing carries a real cash-timing cost; it does not erase the cash, but it slows the conversion, and it is the first place a deteriorating fixed-bid book would show up.

Adjusted earnings, drawn conservatively

Where many companies use "adjusted" figures to inflate a story, Cognizant's adjustments run the other way at the operating line. Reported 2025 operating margin of 16.1% is higher than the adjusted 15.8%, because the largest 2025 item — a $62 million gain on the sale of property — is stripped out of the adjusted number [17]. The EPS bridge from $4.56 GAAP to $5.28 adjusted is dominated by the legitimately one-time OBBBA charge, not by recurring "special items."

Loading...

Source: FY2025 10-K, non-GAAP reconciliation [18].

One item worth watching is the cadence of restructuring. Cognizant ran a "NextGen" program in 2023–2024 that produced a $134 million operating charge in 2024, excluded from adjusted results [19]. It is now launching "Project LEAP," expected to cost $230 million to $320 million — substantially all in 2026 — again to be adjusted out of non-GAAP measures [20]. A company that runs a named, adjusted-out restructuring program every two to three years is, in effect, treating a recurring cost as a series of one-offs. The mitigant is that the magnitudes are modest (roughly 1% to 1.5% of revenue, spread over a year) and management has attached a measurable payoff: $200 million to $300 million of 2026 savings, with full-year benefit in 2027, funding the raised 16–16.2% margin guidance [21]. Whether that payoff reaches reported margins will show whether these are genuinely non-recurring.

What would change the read

On the evidence, the cash behind the valuation is real: conversion is steady near 1.1x once the two tax one-offs are removed, capital intensity and equity dilution are low, and the adjustments are conservative rather than flattering. The honest qualifier is that the headline free-cash-flow yield is drawn from the best year. On 2025's $2.6 billion of free cash flow, the yield against roughly $21 billion of market value is above 12%; on the five-year average of about $2.18 billion, it is closer to 10% — still a double-digit yield, but not the peak figure. Management's own 2026 guidance frames the steady state honestly: free-cash-flow conversion of 90% to 100% of net income, and a normalized 25–26% tax rate [22].

The read would weaken on two specific signals: DSO climbing past the mid-80s while cash conversion falls below 1.0x on a normalized basis — evidence the outcome-based book is trapping cash rather than merely timing it — or Project LEAP charges recurring in 2027 and beyond without the promised savings appearing in the margin line. Neither is present in the record today; both are cheap to monitor each quarter.